7th Innate Killer Summit (San Diego, California)
Cartherics Chief Development Officer, Dr Nicholas Boyd
The innate cell therapy field is exploding as novel research charges through the clinic, proving its potential as a safe, efficacious, and cost-effective treatment. From 30 March-1 April 2022 Pacific Daylight Time (PDT) industry experts will meet in San Diego, California to discuss the clinical and phase development of NK, Macrophage, γδT and NKT cell therapies for liquid and solid tumors.
On opening day Nicholas will make a presentation entitled “Optimizing Manufacturing Processes for iPSC-derived Cell Therapy Products”. On Friday PDT he will participate in a panel with representatives from Adicet Bio and Cellularity. They will discuss the complexity of identifying ‘optimal’ donors for off-the-shelf therapies.